Genome-wide DNA hypomethylation was one of the first epigenetic alterations described in cancer cells. However, the cause of this hypomethylation is still poorly understood. We have previously developed a line of primary mesenchymal stem cells (MSC, the putative origin of various types of sarcoma) in which five oncogenic steps toward a fully transformed state are sequentially introduced including: human telomerase, inactivation of p53 and pRb tumor suppressor genes and activation of the oncogenes c-Myc and H-Ras. We hypothesized that DNA hypomethyation would occur during stepwise transformation of MSC and could be a model to investigate the mechanism of global hypomethylation in cancer. Here we show, firstly, that satellite-2 and long interspersed nuclear element 1 repetitive elements became hypomethylated (54 and 30% reduction, respectively) on the introduction of oncogenic H-Ras after the final step of transformation. Secondly, we observed hypomethylation only after 4 weeks in culture following the introduction of H-Ras, suggesting a gradual loss of methylation. Finally, using an inducible estrogen receptorRas fusion construct, we were able to transform MSC's in the absence of detectable hypomethylation, suggesting that it was not a requirement for transformation. These studies show that DNA hypomethylation can occur late during stepwise transformation, although in vitro transformation could also take place in the absence of hypomethylation. These data support the hypothesis that DNA hypomethylation occurs via a gradual mechanism and is not a requirement for transformation.
Genome-wide DNA hypomethylation was one of the first epigenetic alterations described in cancer cells. However, the cause of this hypomethylation is still poorly understood. We have previously developed a line of primary mesenchymal stem cells (MSC, the putative origin of various types of sarcoma) in which five oncogenic steps toward a fully transformed state are sequentially introduced including: human telomerase, inactivation of p53 and pRb tumor suppressor genes and activation of the oncogenes c-Myc and H-Ras. We hypothesized that DNA hypomethyation would occur during stepwise transformation of MSC and could be a model to investigate the mechanism of global hypomethylation in cancer. Here we show, firstly, that satellite-2 and long interspersed nuclear element 1 repetitive elements became hypomethylated (54 and 30% reduction, respectively) on the introduction of oncogenic H-Ras after the final step of transformation. Secondly, we observed hypomethylation only after 4 weeks in culture following the introduction of H-Ras, suggesting a gradual
Introduction
Many cancer types show hallmark epigenetic changes including characteristic histone modifications, gene-specific hypermethylation and genome-wide hypomethylation (1) . Of these, the first to be described was genome-wide hypomethylation, a decrease in the overall genomic methylcytosine content from $4% in normal tissue to 2-3% in cancer (2) . This change was first observed in a 1983 study comparing lung and colon carcinomas to adjacent normal tissue, demonstrating that overall genomic methylcytosine levels were lower in malignant tissues (2) . This observation has been reproducibly repeated in comparisons of a wide range of cancers and normal tissues using a variety of different assays (3) (4) (5) (6) (7) (8) . DNA hypomethylation may also be particularly important in tumor progression or metastasis (9) .
Despite these numerous observations of genome-wide hypomethylation in cancer, relatively little is known about the mechanism for this loss of methylation. Most studies to date have been conducted in primary cancer tissues compared with corresponding matched or unmatched normal tissues. In doing so, a specific link between a particular genetic or epigenetic change and the induction of genome-wide hypomethylation cannot be established due to cellular heterogeneity and the genetic/epigenetic background of tumors compared with corresponding normal tissues. Furthermore, although matched cases and control samples remove most of the genetic variation, there have been no studies conducted in a specific cellular population via transformation with defined genetic or epigenetic changes to determine the timing of hypomethylation.
DNA methylation patterns result from competing processes that establish, maintain and remove this epigenetic mark. Any shift in the balance of these processes could therefore result in genome-wide alterations to DNA methylation, such as genome-wide hypomethylation. Such hypomethylation may occur in a 'passive' manner through inefficient DNA methylation maintenance (10) (11) (12) . Additionally, disruption of de novo methyltransferase expression could also induce global hypomethylation (13) (14) (15) . Alternatively, hypomethylation may occur in an 'active' manner by direct enzymatic removal of methyl groups from DNA. Although active DNA demethylation has been observed during early mouse embryogenesis, a DNA demethylase in mammalian cells has not yet been definitively identified (16) . Studies in zebrafish and Xenopus models have produced promising indications that the DNA damage response protein growth arrest and DNA-damage-inducible, alpha may act in combination with methylCpG binding domain protein 4 and activation-induced cytidine deaminase as a DNA demethylase complex, although other reports dispute these findings (17) (18) (19) . An important factor distinguishing passive from active demethylation processes is the time period over which this loss of methylation takes place. Active demethylation should take place in a short time frame in the absence of DNA replication as observed in early mouse embryogenesis. Conversely, passive demethylation requires DNA replication and would be expected to occur as a more gradual decline over time with each round of DNA replication.
On the basis that stem cells may be the targets of transformation processes, our laboratory has developed a line of primary human mesenchymal stem cells (thought to be the origin of various types of sarcoma) in which five oncogenic steps toward a fully transformed state are sequentially introduced including: human telomerase, necessary to extend the life span of MSC in culture, HPV E6 and E7 to inactivate the p53 and pRb tumor suppressor genes, respectively, SV40 small-T antigen to activate the oncogene c-Myc and oncogenic H-Ras (Figure 1 ). The validity of this model was demonstrated by anchorage-independent growth, tumor growth in immunodeficient mice and gene expression profiles consistent with transformed cells and has been used to identify novel anticancer drug targets (20, 21) .
This stepwise model of MSC transformation provides an experimental system in which to study epigenetic changes as it allows a direct comparison of normal cells (parental mesenchymal stem cells) to equivalent transformed cells derived from the same lineage. Furthermore, by inducing transformation in a stepwise manner, a link between each of the oncogenic 'hits' and the subsequent epigenetic changes could be established. We hypothesized that global DNA hypomethyation occurs during stepwise transformation of MSC. This investigation could therefore provide an indication of the causes of global hypomethylation in cancer and whether these changes are early or late events during transformation.
and Human embryonic kidney 293T cells were maintained in Dulbecco's modified Eagle's medium (Gibco; Invitrogen, Carlsbad, CA) supplemented with 10% heat inactivated fetal calf serum (Gibco), 100 U/ml penicillin G and 100 lg/ml streptomycin (Gibco). All cells were grown at 37°C, 5% CO 2 at 100% humidity. Cell culture plastics were from Corning (Corning Incorporated, Corning, NY). Cells were kept at subconfluent levels and were typically passaged when 70-80% confluent.
Tumor growth in athymic mice Genomic DNA was obtained from tumors grown from transformed MSC cell line (MSC 5) injected subcutaneously into the flanks of athymic mice, as described previously (20) .
Retrovirus production and infection of target cells
Retroviruses containing H-Ras V12 in the pWZL plasmid were produced by transfection of 293T cells using polyethylenimine (Sigma, Dorset, UK) using standard protocols (20) . Transfection efficiency was monitored by parallel transfection with pMSCV (YFP) vector. Virus was harvested 48 h posttransfection by removing supernatant and passing it through a 0.45 lm filter. Target cells were seeded at 6 Â 10 5 cells per 10 cm dish the day before infection. Retroviral supernatant of 0.5 ml was added to each 10 cm dish and replaced with fresh full media after 5 h. Infection efficiency was assessed by monitoring the percentage of YFP-positive cells 24 h after infection with pMSCV (YFP) retrovirus. Antibiotic selection of infected cells was commenced 48 h following infection and continued until no viable cells were remaining in the control population without the resistance cassette.
Cell viability assay
Cell viability and growth were assessed using the CellTiter 96 AQueous One Solution Cell Proliferation Assay (Promega, Madison, WI) and the manufacturer's protocol. Briefly, cells were seeded at a density of 1000 cells per well containing 100 ll media in a 96-well plate. Viable cell numbers were determined at the initial time point (0 h) and at 24, 48 and 72 h. Absorbance at 490 nm was recorded using a Fluoroskan spectrophotometer (Thermo Fisher, Waltham, MA). Cell lines were assayed in triplicate for each time point, with blank readings obtained from wells containing media only.
Genomic DNA extraction Genomic DNA was extracted with phenol-chloroform as described previously (adapted from NAR 16, 1215 NAR 16, , 1988 . Typical cell pellets ($1 Â 10 6 cells) were resuspended in 300 ll nuclei lysis solution [0.1 M Tris pH8, 2 mM ethylenediaminetetraacetic acid pH8, 0.1 M NaCl, 0.33 mg/ml proteinase K and 0.66% sodium dodecyl sulfate (SDS)] and incubated at 60°C for 90 min or until homogenous. Following protein precipitation and phenolchloroform extraction, the DNA was precipitated with a final concentration of 0.2 M sodium acetate and 75% ethanol and the DNA pellet was dissolved in 50 ll of 10 mM Tris buffer. Genomic DNA was stored at 4°C until used.
Bisulfite conversion of DNA One microgram of genomic DNA was diluted in water to a final volume of 10 ll. One microliter 3 M NaOH was added to a final concentration of 0.3 M. The samples were incubated at 42°C for 20 min and cooled on ice. Sodium bisulfite solution was prepared by adding 4.56 g sodium bisulfite (Sigma) to 8 ml 0.3 M NaOH and heating at 55°C in the dark until dissolved. Hydroquinone solution was prepared by adding 55 mg hydroquinone (Sigma) to 50 ml water and heating at 55°C in the dark until dissolved. Sodium bisulfite solution (104 ll) and 10 mM hydroquinone (6 ll) solution were added to each sample, followed by a 5 h incubation at 55°C in the dark. Following bisulfite conversion, DNA was recovered using Microcon centrifugal filters (Millipore, Billerica, MA). The samples were washed three times with water and desulphonated with 0.1 M NaOH for 5 min. Following a further wash, DNA was eluted in 50 ll 10 mM Tris buffer and stored at À20°C.
To control for the efficiency of the bisulfite conversion, all samples for each experiment were treated in the same bisulfite reaction along with fully methylated and unmethylated controls. To generate fully methylated reference DNA, 100 lg peripheral blood leukocyte DNA (Promega) was incubated with the M.SssI DNA methylase (New England Biosciences, Ipswich, MA) at a concentration of 1 U/lg DNA and 0.16 mM S-adenosyl-methionine (New England Biosciences) overnight at 37°C. The following day, the reaction mixture was supplemented with 0.2 mM S-adeno-methionine and 0.065 U/ll M.SssI followed by another overnight incubation at 37°C. Samples were stored at 4°C. Fully unmethylated DNA was obtained by whole genome amplification of MSC 5 DNA using the Illustra GenomiPhi V2 kit (GE Healthcare, Chalfont St Giles, UK) as per manufacturer's instructions. The amplified samples, containing $4 lg DNA, were stored at 4°C until used.
MethyLight quantitative polymerase chain reaction
Methylight reactions were performed as described previously (5) . Quantitative polymerase chain reactions (PCRs) were conducted in a 30 ll reaction volume containing $60 ng bisulfite-converted DNA, 0.3 lM forward and reverse primers and 0.1 lM probe with the remaining volume made up with TaqMan master mix No AmpErase (Applied Biosystems, Carlsbad, CA). Reactions were performed on an Eppendorf Realplex 4 (Eppendorf, Hamburg, Germany) with the following PCR conditions-95°C for 15 min followed by 50 cycles of 95°C for 15 s and 60°C for 1 min. Primers (Operon, Huntsville, AL) and probes (Applied Biosystems for minor-groove binder-labeled probes and Operon for Black Hole Quencher-1-labeled probes) are detailed in supplementary Table 1 (available at Carcinogenesis Online). All samples were assayed in triplicate for Transformation induces gradual hypomethylation each element. Fold change in methylation relative to the fully methylated reference was quantified by the comparative C t (fluorescence threshold value) method using the Alu-C4 reaction as a loading control, according to the following formulae:
DC tðSampleÞ 5C tðSampleÞ À C tðAluC4Þ ; DDC t 52 ðDCtðMeth:ReferenceÞÀDCtðSampleÞÞ :
Bisulfite sequencing Primers were designed using the Primer3 software (http://frodo.wi.mit.edu/) against the same genomic regions assayed by MethyLight. PCR of the Alu, satellite-2 (Sat2) and long interspersed nuclear element 1 (LINE1) repetitive elements was performed in a 30 ll reaction volume containing 0.3 lM forward and reverse primers (Operon), 3.5 mM MgCl2, 200 lM deoxyribonucleotide triphosphates (Yorkshire Bioscience, York, UK), 1 U HotStartTaq (QIAGEN, Crawley, UK) and 60 ng template. PCR cycling conditions and primers were as follows: 95°C for 15 min, followed by 35 cycles of 95°C for 30 s, 60°C (LINE1) or 55°C (Sat2 and Alu) for 20 s and 72°C for 30 s and finally 72°C for 5 min. Amplification of the correct PCR products was verified by gel electrophoresis, followed by cloning and sequencing of individual products using pGEM-T Easy and the manufacturer's protocol (Promega). Sequencing was performed by direct ABI dye-terminator sequencing with a minimum of 10 clones sequenced per amplicon.
Western blot Cells were lysed in RIPA buffer containing protease and phosphatase inhibitor cocktails (Sigma), [150 mM NaCl, 50 mM Tris-HCl pH 7.5, 1% (vol/vol) NP40, 0.5% (wt/vol) deoxycholic acid, 0.1% (wt/vol) SDS, 1:100 protease inhibitor cocktail, 1:100 phosphatase inhibitor cocktail I and 1:100 phosphatase inhibitor cocktail II]. Lysis buffer of 50-100 ll was added directly to cells in a 10 cm dish that had been washed in cold phosphate-buffered saline. The cells were scraped, aspirated into a 1.5 ml eppendorf tube and incubated for 30 min on ice. Samples were centrifuged at 13 000 r.p.m. for 30 min at 4°C and the supernatant transferred to a fresh tube. Protein was quantified by the Bradford assay (Bio-rad, Hertfordshire, UK). Typically, 20 lg of protein was mixed with SDSpolyacrylamide gel electrophoresis sample loading buffer, heated at 100°C for 3 min and allowed to cool before electrophoresis. SDS-polyacrylamide gel electrophoresis was performed using standard procedures (22) . Densitometric quantification of bands was performed on scanned images using the Scion Image software (Scion Corporation, Frederick, MD). Antibodies and concentrations used for western blots are described in the supplementary Table 2 (available at Carcinogenesis Online).
Soft agarose transformation assay
Transformation was assessed by anchorage-independent growth of cells in soft agarose. Plates were prepared with a 2 ml layer of 0.6% low-melting point agarose (Sigma) in Dulbecco's modified Eagle's medium (Gibco). Cells (10 4 ) were resuspended in 0.35% low-melting point agarose in Dulbecco's modified Eagle's medium and seeded in triplicate on the 0.6% agarose layer in six-well plates. Cells were grown at 37°C for 12 days, with colony number and size quantified visually at Â40 magnification on the Axiovert 100 microscope and with the SynGene G:Box and GeneTools software.
Statistical analyses
Student's t-tests were used for normally distributed data and conducted using Microsoft Excel with unequal sample variance, with P , 0.05 considered statistically significant. Wilcoxon rank-sum test was conducted for nonnormally distributed data using the statistical package R. Paired Wilcoxon rank-sum test was used to compare the methylation percentages of individual CpG sites between cell lines in the bisulfite sequencing data. Error bars are standard error of the mean (SEM) unless otherwise stated.
Results

Global methylation analysis by MethyLight
In order to investigate repetitive element methylation in the MSC cell lines, the quantitative reverse transcriptase polymerase chain reaction-based method MethyLight was utilized to assess methylation of the short interspersed nuclear element Alu, pericentromeric Sat2 and LINE1. Methylation of these repetitive elements has previously been shown to correlate strongly with genome-wide methylation as measured by high performance liquid chromatography (5). MethyLight was initially conducted with parental (MSC 0) and fully transformed (MSC 5) cell lines and in tumors derived from MSC 5 grown in athymic mice (Figure 2 ). These data revealed no significant change in Alu methylation (MSC 0 versus MSC 5 t-test P 5 0.69; MSC 0 versus tumor t-test P 5 0.22). However, we observed a significant decrease in Sat2 and LINE1 methylation in MSC 5 (36 and 34% of MSC 0 methylation, respectively) compared with MSC 0 (P 5 0.01 and P 5 0.02, respectively) (Figure 2b and c). To identify the step at which this decrease in methylation occurred during transformation, Sat2 methylation was assessed in more detail at each step during transformation of MSC (Figure 2d ). This element was chosen for further investigation because it has previously been shown to provide a strong correlation with global methylation levels and also displayed the most significant decrease in methylation in this model (5) . These data demonstrate a decrease in methylation between MSC 0 and MSC 1 (on the introduction of human telomerase reverse transcriptase, followed by a return to similar levels with p53 inhibition in MSC 2E6. On further hits, methylation levels remained similar to parental MSC levels until the introduction of H-Ras between MSC 4 and MSC 5, at which point a significant decline in methylation was observed. The hypomethylation was also maintained in the MSC 5 tumors grown in mice.
Bisulfite sequencing confirmation of MethyLight data To confirm the results observed by MethyLight, bisulfite sequencing of the Alu, Sat2 and LINE1 elements was conducted (Figure 3) . The PCR products covered the same regions used in MethyLight including three CpG dinucleotides in the Alu element, 11 in LINE1 and 10 in Sat2. Analysis of parental and transformed MSC confirmed the Methy Light data, demonstrating a significant decrease in methylation for both Sat2 and LINE1 elements, but no change in Alu methylation (Figure 3b ). Absolute methylation levels of Sat2 dropped from 62.9% in the MSC 0 to 29.2% in the MSC 5 cell lines (P 5 0.01). The LINE1 methylation levels dropped from 74.4 to 52.2% between the MSC 0 and MSC 5 cell lines (P 5 0.009). 
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Constitutive H-Ras V12 overexpression in MSC 4 and Sat2 methylation analysis To determine whether the repetitive element hypomethylation observed in the original MSC 5 cells could be recapitulated, oncogenic H-Ras V12 was constitutively overexpressed in MSC 4 cells. Retrovirus containing H-Ras V12 within the pWZL vector was generated alongside empty vector control virus. Infection of MSC 4 cells was performed in triplicate for each virus, with hygromycin resistant cells selected over the course of 1 week following infection. After selection, H-Ras expression was confirmed by western blot and transformation of the cells was assessed by anchorage-independent growth in soft agarose (Figure 4 ). This indicated that MSC 4 cells expressing H-Ras V12 were transformed in vitro, whereas cells containing the empty vector control (pWZL) were not. Sat2 methylation levels in these cells were assayed by MethyLight, indicating no significant difference between H-Ras V12 and empty vector containing cells 1 week following infection (Figure 4c ). Cells were further cultured as normal for 4 weeks, with Sat2 methylation levels assessed again at this point (Figure 4c) . These MethyLight data demonstrate a significant reduction (P , 0.001) in Sat2 methylation levels between MSC 4 expressing H-Ras V12 and empty vector control cells, observed in all three infections, after 4 weeks in culture.
Inducible H-Ras V12 expression in MSC 4
The original MSC 5 population was established by infecting MSC 4 cells with retrovirus containing the oncogenic H-Ras V12 construct and selecting cells with hygromycin resistance. The time period over which infection and selection takes place makes it difficult to establish exactly when selected cells begin to express H-Ras V12 or the point at which global hypomethylation may take place. A more efficient way to explore the time course of demethylation following H-Ras expression is to use an inducible system. To this end, an inducible H-Ras V12 construct was used. This construct consisted of the full coding sequence for oncogenic H-Ras V12 and a mutated form of the estrogen receptor (ER TM ) expressed together as a fusion protein. ER TM is sensitive to 4-hydroxytamoxifen (4-OHT) but not to the natural ligand for the wild-type receptor (17b-estradiol) (23) . In the absence of 4-OHT, the fusion protein is complexed with hsp90 in the cytoplasm, preventing downstream H-Ras signaling. This interaction is abolished when treated with 4-OHT, allowing active H-Ras signaling (24) .
Retroviruses containing the pWZL-ER TM -Ras construct and empty vector control (pWZL) were produced and used to infect MSC 4 cells. 
Global methylation levels following ER TM -H-Ras induction
To investigate whether repetitive element hypomethylation occurs following ER TM -H-Ras induction, MSC 4 ER-Ras and MSC 4 pWZL cells were grown in the presence and absence of 500 nM 4-OHT for 1 month, with methylation of Alu, LINE1 and Sat2 elements assayed by MethyLight 72 h after the addition of 4-OHT and once a week for 4 weeks thereafter ( Figure 6 ). Continued expression of the fusion protein and elevated pERK levels in MSC 4 ER-Ras cells were confirmed at the final time point by western blot (supplementary Figure 2 is available at Carcinogenesis Online). The results indicated that Alu, LINE1 and Sat2 methylation levels as measured by MethyLight do not differ significantly between MSC 4 ER-Ras and MSC 4 pWZL cells treated with 4-OHT at any of the time points (Figure 6a-c) . This result was confirmed by bisulfite sequencing of the Sat2 element (Figure 6d ). These data indicated that hypomethylation of these repetitive elements did not take place during transformation following inducible expression of ER TM -H-Ras and that hypomethylation of these elements was not essential for in vitro transformation.
Discussion
Genome-wide hypomethylation has been observed in a wide range of cancers using various techniques, many of which utilize repetitive elements as markers for genome-wide methylation status. Despite the wealth of studies on global DNA hypomethylation, very little progress has been made to elucidate the mechanism for this loss of methylation. Although genome-wide hypomethylation in cancer has traditionally been viewed as an early event during transformation, few studies have addressed whether hypomethylation is causative of transformation (25, 26) . Induction of genome-wide hypomethylation by dnmt1 knockdown has been shown to increase tumorigenicity, suggesting a causal relationship between these two events (27) . However, there is a wide diversity of the timing and the nature of genome-wide hypomethylation reported during carcinogenesis, indicating that this change is not always an early requirement for transformation (8) .
Our studies of this transformed mesenchymal stem cell model have revealed a number of interesting findings. Firstly, hypomethylation of the Sat2 and LINE1 repetitive elements was observed during transformation in this model, with the decrease in methylation occurring at the introduction of human telomerase reverse transcriptase and on the introduction of oncogenic H-Ras at the final step. In this present study, we have focused our attention on the consistent loss of methylation between the MSC 4 (not transformed) and MSC 5 (transformed) stages of this model as this represents the defined transition between pre-and post-transformation (20) . The absolute methylation levels of the Sat2 element determined 
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by bisulfite sequencing showed a reduction from 60% (MSC 4) down to 30% (MSC 5) that is consistent with the overall reduction observed in cancer cells (4% down to 2% total methylcytosine). Hypomethylation of these elements has been widely observed and shown to strongly correlate with genome-wide methylation levels (5, 6) . Previous reports have suggested links between Ras signaling and changes in DNA methylation (28, 29) . These include hypermethylation of a CpG island upstream of the clusterin promoter and a CpG island of the matrix metalloproteinase 2 promoter in H-Ras-transformed rat fibroblasts (30) . As well as this role in DNA hypermethylation, studies have suggested that Ras may also be involved in the induction of DNA hypomethylation. For example, v-H-Ras induced DNA demethylation in mouse embryonal P19 cells (31) . Although this study demonstrated an interaction between Ras signaling and the control of DNA methylation in cells, our investigation is the first to link Ras signaling and hypomethylation during the process of transformation in human cells.
Secondly, we observed hypomethylation after 4 weeks in culture following the introduction of H-Ras into MSC 4 cells. The widespread incidence of genome wide hypomethylation in a range of tumors, including benign neoplasms, has suggested that this epigenetic change occurs early during the process of transformation (26) . Our results indicate that hypomethylation occurred only in fully transformed cells following the final oncogenic 'hit' suggesting that hypomethylation occurred via slow gradual loss of methylation. However, transformation in this model is induced by a series of genetic hits and may not faithfully recapitulate the true early epigenetic changes occurring during in vivo transformation (26) . Thus, we cannot exclude that genome-wide hypomethylation is a late event in our model but occurs earlier during in vivo oncogenesis as a prelude to further genetic and epigenetic changes.
Lastly, using inducible expression of the fusion protein ER TM -H-Ras, we were unable to recapitulate the loss of methylation observed with the constitutive expression of H-Ras. Despite the lack of hypomethylation, these cells were transformed as shown by their ability to form colonies in soft agarose. This suggests that genomic hypomethylation is not essential for in vitro transformation of these cells, however, we cannot exclude the possibility that hypomethylation of these sequences is required for other features of transformation such as invasiveness and cell migration. Genome-wide loss of methylation in mice containing a hypomorphic allele of dnmt1 can result in transformation and increased incidence of soft tissue sarcomas (27, 32) . In contrast, another mouse model of genome-wide hypomethylation induced by dnmt1 knockdown notes opposing effects on the growth of different tumor types (33) . Together, these reports show that genome-wide hypomethylation promotes some instances of transformation, but there is no definitive demonstration that hypomethylation is a strict requirement of transformation.
The timing of genome-wide hypomethylation during the development of cancer could also provide an indication of whether this change is causative for transformation. Many studies have suggested that DNA hypomethylation is an early event in transformation (4, 34, 35) . The consensus from these studies is that global hypomethylation in the adjacent normal tissue indicates this change is an early event in the transformation process, potentially leading to karyotypic instability and further oncogenic changes. However, several other investigations have failed to detect reduced global methylcytosine levels in benign lesions or during malignant tumor progression (8, 9, (36) (37) (38) . Our study agrees with the latter observation, that genomic hypomethylation of Sat2 and LINE1 elements are not an early oncogenic change and thus unlikely to be causative of transformation in this model.
Why the inducible inducible ER TM -H-Ras did not promote hypomethylation, when the constitutive H-Ras did, is not clear. Differences in the rate of methylation loss between the two vector systems may account for this effect. Alternatively, although the activity of the inducible ER TM -H-Ras V12 was extensively characterized, differences between this fusion protein and H-Ras V12 , such as the additional 316 amino acids on the C-terminal end of the protein, may slightly interfere with protein-protein interactions of Ras with effector molecules and have a knockon effect on the downstream consequences such as hypomethylation. Additional investigation of these two systems may provide further insight into the mechanism of genomic hypomethylation during transformation.
Here, we show that hypomethylation can occur late during step-wise transformation, although it is not a necessary event for transformation in this model. Furthermore, in the instance where hypomethylation was observed, this was a late event in this stepwise genetic model, occurring subsequent to a common genetic aberration in cancer. In conclusion, this study has demonstrated a link between H-Ras and hypomethylation of repetitive elements in a stepwise model of transformation in human MSC. This model provides a controlled background in which known genetic hits can be linked to observed epigenetic changes and provides a valuable tool for further investigating the mechanism of genome-wide hypomethylation and the consequences of this change. Supplementary Figures 1 and 2 and Tables 1 and 2 
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